[
  {
    "title": "FDA Expands Surprise Inspections At Foreign Drug And Food Facilities, Targets Double Standards In Overseas Manufacturing Oversight",
    "link": "https://finance.yahoo.com/news/fda-expands-surprise-inspections-foreign-185407796.html"
  },
  {
    "title": "Jim Cramer on Pfizer (PFE): “Trying Big Targets, but New Wins Still Elusive”",
    "link": "https://finance.yahoo.com/news/jim-cramer-pfizer-pfe-trying-175025216.html"
  },
  {
    "title": "Trump Is Threatening Big Pharma With Tariffs. Tax Changes Might Work Better.",
    "link": "https://finance.yahoo.com/m/a4bec800-6f4b-30e9-8edf-e6305a9166c4/trump-is-threatening-big.html"
  },
  {
    "title": "Market Chatter: Expanded Indication for GSK, Pfizer RSV Vaccines Faces Government Review",
    "link": "https://finance.yahoo.com/news/market-chatter-expanded-indication-gsk-201334412.html"
  },
  {
    "title": "Trump Sets Pharma Tariffs Deadline. The Fallout for Lilly, Pfizer, Other Drugmakers.",
    "link": "https://finance.yahoo.com/m/4905bd6c-d6c2-31c3-8bdf-25145b8cfb69/trump-sets-pharma-tariffs.html"
  },
  {
    "title": "Moderna Sharpens Pipeline Focus as COVID-19 Vaccine Demand Ebbs in Q1",
    "link": "https://finance.yahoo.com/news/moderna-sharpens-pipeline-focus-covid-135400467.html"
  },
  {
    "title": "Do These 3 Checks Before Buying Pfizer Inc. (NYSE:PFE) For Its Upcoming Dividend",
    "link": "https://finance.yahoo.com/news/3-checks-buying-pfizer-inc-131303373.html"
  },
  {
    "title": "Why Viking Therapeutics Stock Surged Nearly 20% Higher in April",
    "link": "https://finance.yahoo.com/news/why-viking-therapeutics-stock-surged-083331825.html"
  },
  {
    "title": "Optimism Is Back for Biotech Stocks. This Time, It Could Last.",
    "link": "https://finance.yahoo.com/m/9e07f027-7fa1-3b86-9f03-26df8aa0eb8f/optimism-is-back-for-biotech.html"
  },
  {
    "title": "Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It",
    "link": "https://finance.yahoo.com/news/pfizer-inc-pfe-trending-stock-130012252.html"
  },
  {
    "title": "Top Wide-Moat Stocks to Invest in for Long-Term Growth",
    "link": "https://finance.yahoo.com/news/top-wide-moat-stocks-invest-122200214.html"
  },
  {
    "title": "Pfizer Stock Up 5% Following Q1 Results: Time to Buy, Sell or Hold?",
    "link": "https://finance.yahoo.com/news/pfizer-stock-5-following-q1-121000525.html"
  },
  {
    "title": "Is Pfizer Inc. (PFE) The Most Profitable Cheap Stock to Buy Now?",
    "link": "https://finance.yahoo.com/news/pfizer-inc-pfe-most-profitable-152058132.html"
  },
  {
    "title": "Is Pfizer Inc.'s (NYSE:PFE) Stock Price Struggling As A Result Of Its Mixed Financials?",
    "link": "https://finance.yahoo.com/news/pfizer-inc-nyse-pfe-stock-120028400.html"
  },
  {
    "title": "Trump Says Drug Tariffs Are Coming. Big Pharma Execs Can’t Figure Out How Much to Worry.",
    "link": "https://finance.yahoo.com/m/64ec4ca8-6882-3966-87c1-a6c7fec387aa/trump-says-drug-tariffs-are.html"
  },
  {
    "title": "Zacks.com featured highlights Fox, Universal Technical Institute, Pfizer, Tenet Healthcare and Newmont",
    "link": "https://finance.yahoo.com/news/zacks-com-featured-highlights-fox-125900043.html"
  },
  {
    "title": "3 No-Brainer Ultra-High-Yield Dividend Stocks That Are Begging to Be Bought in May",
    "link": "https://finance.yahoo.com/news/3-no-brainer-ultra-high-075100013.html"
  },
  {
    "title": "Arvinas Inc (ARVN) Q1 2025 Earnings Call Highlights: Record Revenue Surge and Strategic ...",
    "link": "https://finance.yahoo.com/news/arvinas-inc-arvn-q1-2025-070309524.html"
  },
  {
    "title": "'Declare victory and move on': Eli Lilly CEO on Trump tariff threat",
    "link": "https://finance.yahoo.com/news/declare-victory-and-move-on-eli-lilly-ceo-on-trump-tariff-threat-160646465.html"
  },
  {
    "title": "LLY's Q1 Earnings Miss, Mounjaro & Zepbound Drive Sales, Stock Down",
    "link": "https://finance.yahoo.com/news/llys-q1-earnings-miss-mounjaro-155100125.html"
  },
  {
    "title": "Q1 2025 OPKO Health Inc Earnings Call",
    "link": "https://finance.yahoo.com/news/q1-2025-opko-health-inc-125729678.html"
  },
  {
    "title": "Eli Lilly stock slips despite earnings beat, reaffirmed 2025 guidance",
    "link": "https://finance.yahoo.com/news/eli-lilly-stock-slips-despite-earnings-beat-reaffirmed-2025-guidance-125448495.html"
  },
  {
    "title": "Looking for Earnings Beat? Buy These 5 Top-Ranked Stocks",
    "link": "https://finance.yahoo.com/news/looking-earnings-beat-buy-5-124000418.html"
  },
  {
    "title": "Zacks.com featured highlights Centene, Pediatrix Medical, Pfizer, StoneCo and Banco Santander",
    "link": "https://finance.yahoo.com/news/zacks-com-featured-highlights-centene-085000527.html"
  },
  {
    "title": "Want Safe Dividend Income in 2025 and Beyond? Invest in the Following 3 Ultra-High-Yield Stocks.",
    "link": "https://finance.yahoo.com/news/want-safe-dividend-income-2025-081500424.html"
  },
  {
    "title": "OPKO Health Inc (OPK) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial ...",
    "link": "https://finance.yahoo.com/news/opko-health-inc-opk-q1-071721036.html"
  },
  {
    "title": "BridgeBio Breaks Out After Pfizer-Rivaling Heart Drug Obliterates Sales Expectations",
    "link": "https://finance.yahoo.com/m/5a8020c0-f8e0-3328-a8d5-da7ff63f15de/bridgebio-breaks-out-after.html"
  },
  {
    "title": "Pfizer (NYSE:PFE) Reports Q1 Earnings, Reaffirms 2025 Revenue Guidance at US$61-64 Billion",
    "link": "https://finance.yahoo.com/news/pfizer-nyse-pfe-reports-q1-173235366.html"
  },
  {
    "title": "Company News for Apr 30, 2025",
    "link": "https://finance.yahoo.com/news/company-news-apr-30-2025-131000899.html"
  },
  {
    "title": "Boost Your Portfolio With These 5 Low Price-to-Book Stocks",
    "link": "https://finance.yahoo.com/news/boost-portfolio-5-low-price-130800068.html"
  },
  {
    "title": "Pfizer First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag",
    "link": "https://finance.yahoo.com/news/pfizer-first-quarter-2025-earnings-123725913.html"
  },
  {
    "title": "BridgeBio sales of new heart drug outstrip expectations",
    "link": "https://finance.yahoo.com/news/bridgebio-sales-heart-drug-outstrip-110714431.html"
  },
  {
    "title": "Stock Market Crash: 3 Absurdly Cheap Stocks to Load Up on for the Long Haul",
    "link": "https://finance.yahoo.com/news/stock-market-crash-3-absurdly-110500153.html"
  },
  {
    "title": "Market Rally at Risk as Tariffs Damage Spreads. And 5 Other Things to Know Today.",
    "link": "https://finance.yahoo.com/m/3911d47e-6f63-3408-a9ab-1f314de4849e/market-rally-at-risk-as.html"
  },
  {
    "title": "Pfizer's Dividend Yield Is 7.5%. Is It Still Safe?",
    "link": "https://finance.yahoo.com/news/pfizers-dividend-yield-7-5-101500533.html"
  },
  {
    "title": "Will Pfizer Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback?",
    "link": "https://finance.yahoo.com/news/pfizer-acquire-altimmune-viking-therapeutics-085100117.html"
  },
  {
    "title": "Is Healthcare Losing the Status of Safe Haven? ETFs in Focus",
    "link": "https://finance.yahoo.com/news/healthcare-losing-status-safe-haven-083300838.html"
  },
  {
    "title": "Prediction: Pfizer's Loss May Be Viking Therapeutics' Gain",
    "link": "https://finance.yahoo.com/news/prediction-pfizers-loss-may-viking-071500884.html"
  },
  {
    "title": "Pfizer Inc (PFE) Q1 2025 Earnings Call Highlights: Navigating Revenue Decline and Strategic Growth",
    "link": "https://finance.yahoo.com/news/pfizer-inc-pfe-q1-2025-071156962.html"
  },
  {
    "title": "Q1 2025 Pfizer Inc Earnings Call",
    "link": "https://finance.yahoo.com/news/q1-2025-pfizer-inc-earnings-065551863.html"
  },
  {
    "title": "Buy Pfizer (PFE) Stock for a Rebound After Crushing Q1 EPS Expectations?",
    "link": "https://finance.yahoo.com/news/buy-pfizer-pfe-stock-rebound-003200844.html"
  },
  {
    "title": "Stock Bulls Fuel Best Winning Run Since March 2022: Markets Wrap",
    "link": "https://finance.yahoo.com/news/asian-stocks-edge-barrage-earnings-014255977.html"
  },
  {
    "title": "These Stocks Moved the Most Today: GM, Tesla, Ford, JetBlue, Wolfspeed, SoFi, Nvidia, and More",
    "link": "https://finance.yahoo.com/m/f0c0f99a-882a-3f36-a29b-6bb39cba2324/these-stocks-moved-the-most.html"
  },
  {
    "title": "S&P 500 Stock Pfizer Jumps As Cost-Cutting Bolsters Profit",
    "link": "https://finance.yahoo.com/m/6fd58dae-7780-3d61-b4c8-f887cc9e55e5/s-p-500-stock-pfizer-jumps-as.html"
  },
  {
    "title": "Pfizer Shares Rise on CEO’s Optimism on Threatened Drug Tariffs",
    "link": "https://finance.yahoo.com/m/039e09ae-1aef-3d03-8d50-a51058213dca/pfizer-shares-rise-on-ceo%E2%80%99s.html"
  },
  {
    "title": "Pfizer Cuts Spending on Weaker Sales",
    "link": "https://finance.yahoo.com/video/pfizer-cuts-spending-weaker-sales-192049405.html"
  },
  {
    "title": "Sector Update: Health Care Stocks Higher Tuesday Afternoon",
    "link": "https://finance.yahoo.com/news/sector-health-care-stocks-higher-181755135.html"
  },
  {
    "title": "Pfizer Stock’s 7% Yield Makes It Look Like a Junk Bond—But Better",
    "link": "https://finance.yahoo.com/m/79b51aff-f5e1-3bfd-b3d1-b1d0c2e01990/pfizer-stock%E2%80%99s-7-yield-makes.html"
  },
  {
    "title": "Pfizer Expands Cost-Cutting Measures, Reaffirms Outlook",
    "link": "https://finance.yahoo.com/m/aa09cf82-9814-3446-8d0e-8f482d6bc027/pfizer-expands-cost-cutting.html"
  },
  {
    "title": "Pfizer CEO: 'We should not have tariffs' on pharma",
    "link": "https://finance.yahoo.com/news/pfizer-ceo-we-should-not-have-tariffs-on-pharma-171641146.html"
  },
  {
    "title": "Pfizer Shares Rise After Q1 Profit Beats, Reaffirms 2025 Outlook",
    "link": "https://finance.yahoo.com/news/pfizer-shares-rise-q1-profit-163604707.html"
  },
  {
    "title": "Pfizer Q1 Earnings Beat Estimates, Several Headwinds Hurt Sales",
    "link": "https://finance.yahoo.com/news/pfizer-q1-earnings-beat-estimates-153400888.html"
  },
  {
    "title": "Economic Data Deluge",
    "link": "https://finance.yahoo.com/news/economic-data-deluge-151100432.html"
  },
  {
    "title": "Pfizer Reports Mixed First Quarter, Affirms Full-Year Outlook",
    "link": "https://finance.yahoo.com/news/pfizer-reports-mixed-first-quarter-144710844.html"
  },
  {
    "title": "Pfizer Eyes Acquisitions After Obesity Drug Setback",
    "link": "https://finance.yahoo.com/news/pfizer-eyes-acquisitions-obesity-drug-143221205.html"
  },
  {
    "title": "Pfizer offers 'longer-term' opportunity amid tariff uncertainty",
    "link": "https://finance.yahoo.com/video/pfizer-offers-longer-term-opportunity-143115195.html"
  },
  {
    "title": "Trade Balance in Goods Hits All-Time Record, Plus Q1 Earnings",
    "link": "https://finance.yahoo.com/news/trade-balance-goods-hits-time-142900578.html"
  },
  {
    "title": "Compared to Estimates, Pfizer (PFE) Q1 Earnings: A Look at Key Metrics",
    "link": "https://finance.yahoo.com/news/compared-estimates-pfizer-pfe-q1-140006837.html"
  },
  {
    "title": "GM, UPS, Coca-Cola, Spotify: Stocks to watch today",
    "link": "https://finance.yahoo.com/news/gm-ups-coca-cola-spotify-131400329.html"
  },
  {
    "title": "Pfizer (NYSE:PFE) Misses Q1 Revenue Estimates",
    "link": "https://finance.yahoo.com/news/pfizer-nyse-pfe-misses-q1-122415597.html"
  },
  {
    "title": "Pfizer’s Bourla ‘cautiously optimistic’ on looming US pharma tariffs",
    "link": "https://finance.yahoo.com/news/pfizer-bourla-cautiously-optimistic-looming-121700979.html"
  },
  {
    "title": "Pfizer (PFE) Surpasses Q1 Earnings Estimates",
    "link": "https://finance.yahoo.com/news/pfizer-pfe-surpasses-q1-earnings-115504229.html"
  },
  {
    "title": "If You'd Invested $10,000 in Pfizer Stock 10 Years Ago, Here's How Much You'd Have Today",
    "link": "https://finance.yahoo.com/news/youd-invested-10-000-pfizer-114500857.html"
  },
  {
    "title": "Biohaven secures $600m financing as it awaits FDA prodrug decision",
    "link": "https://finance.yahoo.com/news/biohaven-secures-600m-financing-awaits-110621672.html"
  },
  {
    "title": "Pfizer reports mixed results in first quarter earnings, reiterates 2025 outlook",
    "link": "https://finance.yahoo.com/news/pfizer-reports-mixed-results-in-first-quarter-earnings-reiterates-2025-outlook-105736856.html"
  },
  {
    "title": "Pfizer: Q1 Earnings Snapshot",
    "link": "https://finance.yahoo.com/news/pfizer-q1-earnings-snapshot-105514725.html"
  },
  {
    "title": "Pfizer leans on cost cuts to offset falling revenue",
    "link": "https://finance.yahoo.com/news/pfizer-beats-profit-estimates-cost-105349474.html"
  },
  {
    "title": "Pfizer Reports Solid First-Quarter 2025 Results And Reaffirms 2025 Guidance",
    "link": "https://finance.yahoo.com/news/pfizer-reports-solid-first-quarter-104500122.html"
  },
  {
    "title": "US Stock Futures Edge Higher Tuesday: Expert Warns Of 'Perfect Volatility Storm' With Major Earnings And Economic Data Due This Week",
    "link": "https://finance.yahoo.com/news/us-stock-futures-edge-higher-103256866.html"
  },
  {
    "title": "The Zacks Analyst Blog Highlights Pfizer, Eli Lilly, Amgen, Biogen and Regeneron",
    "link": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-pfizer-103200684.html"
  },
  {
    "title": "Zacks.com featured highlights StoneCo, Carriage Services, Associated Banc-Corp and Pfizer",
    "link": "https://finance.yahoo.com/news/zacks-com-featured-highlights-stoneco-090800568.html"
  },
  {
    "title": "Coca-Cola earnings, JOLTS, Consumer Confidence: What to Watch",
    "link": "https://finance.yahoo.com/video/coca-cola-earnings-jolts-consumer-230000860.html"
  },
  {
    "title": "Pfizer Q1 Preview: EPS, Revenue Slide Expected",
    "link": "https://finance.yahoo.com/news/pfizer-q1-preview-eps-revenue-195137364.html"
  },
  {
    "title": "Pfizer (NYSE:PFE) Unveils Promising Preclinical Data On First-In-Class Oncology Drug",
    "link": "https://finance.yahoo.com/news/pfizer-nyse-pfe-unveils-promising-173724581.html"
  },
  {
    "title": "Will These 5 Big Drug Stocks Surpass Q1 Earnings Forecasts?",
    "link": "https://finance.yahoo.com/news/5-big-drug-stocks-surpass-160800036.html"
  },
  {
    "title": "Eli Lilly, Pfizer Risk Billions in Losses From Trump's 25% Pharma Tariffs",
    "link": "https://finance.yahoo.com/news/eli-lilly-pfizer-risk-billions-152037442.html"
  },
  {
    "title": "4 Top Value Stocks to Invest in as US-Global Trade Talks Unfold",
    "link": "https://finance.yahoo.com/news/4-top-value-stocks-invest-121700241.html"
  },
  {
    "title": "3 Dividend Stocks to Buy and Hold for the Next Decade",
    "link": "https://finance.yahoo.com/news/3-dividend-stocks-buy-hold-114700146.html"
  },
  {
    "title": "Pfizer’s sasanlimab and BCG combo therapy improves EFS in bladder cancer trial",
    "link": "https://finance.yahoo.com/news/pfizer-sasanlimab-bcg-combo-therapy-104404691.html"
  },
  {
    "title": "My 5 Top Stocks to Buy Right Now in This Highly Volatile Market",
    "link": "https://finance.yahoo.com/news/5-top-stocks-buy-now-084800780.html"
  },
  {
    "title": "Pfizer (PFE) Reports Q1: Everything You Need To Know Ahead Of Earnings",
    "link": "https://finance.yahoo.com/news/pfizer-pfe-reports-q1-everything-070739798.html"
  },
  {
    "title": "Pfizer Inc. (PFE): Among Billionaire Ken Fisher’s Healthcare Stock Picks with Massive Upside Potential",
    "link": "https://finance.yahoo.com/news/pfizer-inc-pfe-among-billionaire-190445273.html"
  },
  {
    "title": "1 Stock to Buy, 1 Stock to Sell This Week: Meta Platforms, Pfizer",
    "link": "https://finance.yahoo.com/news/1-stock-buy-1-stock-132043391.html"
  },
  {
    "title": "Pfizer’s Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer",
    "link": "https://finance.yahoo.com/news/pfizer-sasanlimab-combination-significantly-improves-173000786.html"
  },
  {
    "title": "Investing Action Plan: Apple, Amazon, Pfizer, Caterpillar And Sparring With The Fed",
    "link": "https://finance.yahoo.com/m/8a14136c-151e-3e34-8509-e681b8857b6a/investing-action-plan-apple-.html"
  },
  {
    "title": "Biohaven stock slides on withdrawal of European marketing application",
    "link": "https://finance.yahoo.com/news/biohaven-stock-slides-withdrawal-european-150000873.html"
  },
  {
    "title": "Will Pfizer's Non-COVID Drugs Drive Sales Again This Earnings Season?",
    "link": "https://finance.yahoo.com/news/pfizers-non-covid-drugs-drive-110600199.html"
  },
  {
    "title": "Stocks to watch this week: Apple, Microsoft, Shell, HSBC, Lloyds and AstraZeneca",
    "link": "https://finance.yahoo.com/news/apple-microsoft-shell-hsbc-lloyds-astrazeneca-stocks-to-watch-050019911.html"
  },
  {
    "title": "Sector Update: Health Care Stocks Rise Late Afternoon",
    "link": "https://finance.yahoo.com/news/sector-health-care-stocks-rise-200558091.html"
  },
  {
    "title": "Guardant Health, Pfizer Collaborate To Develop New Cancer Therapies Using Liquid Biopsy Platform",
    "link": "https://finance.yahoo.com/news/guardant-health-pfizer-collaborate-develop-193634667.html"
  },
  {
    "title": "Pfizer (NYSE:PFE) Collaborates With Guardant Health on Oncology; Declares US$0.43 Dividend",
    "link": "https://finance.yahoo.com/news/pfizer-nyse-pfe-collaborates-guardant-175629624.html"
  },
  {
    "title": "Is Pfizer Stock A Sell After Abandoning Yet Another Obesity Drug?",
    "link": "https://finance.yahoo.com/m/9a6f7dfd-febf-37fb-912a-e0504d778fbc/is-pfizer-stock-a-sell-after.html"
  },
  {
    "title": "PFE vs. LLY: Which Stock Should Value Investors Buy Now?",
    "link": "https://finance.yahoo.com/news/pfe-vs-lly-stock-value-154005499.html"
  },
  {
    "title": "Eli Lilly (LLY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release",
    "link": "https://finance.yahoo.com/news/eli-lilly-lly-earnings-expected-140156989.html"
  },
  {
    "title": "Are Investors Undervaluing Pfizer (PFE) Right Now?",
    "link": "https://finance.yahoo.com/news/investors-undervaluing-pfizer-pfe-now-134012549.html"
  },
  {
    "title": "Curious about Pfizer (PFE) Q1 Performance? Explore Wall Street Estimates for Key Metrics",
    "link": "https://finance.yahoo.com/news/curious-pfizer-pfe-q1-performance-131519601.html"
  },
  {
    "title": "With 67% institutional ownership, Pfizer Inc. (NYSE:PFE) is a favorite amongst the big guns",
    "link": "https://finance.yahoo.com/news/67-institutional-ownership-pfizer-inc-130012784.html"
  },
  {
    "title": "Stocks That Pay Almost 10% Dividend Yields: Dow and Lyondell",
    "link": "https://finance.yahoo.com/m/4f836d30-d632-3681-8575-9bd09d591ef9/stocks-that-pay-almost-10-.html"
  },
  {
    "title": "Sanofi Q1 Earnings Top Estimates, Dupixent Drives Sales Growth",
    "link": "https://finance.yahoo.com/news/sanofi-q1-earnings-top-estimates-115900224.html"
  },
  {
    "title": "2 No-Brainer Stocks to Buy With Less Than $30",
    "link": "https://finance.yahoo.com/news/2-no-brainer-stocks-buy-104500799.html"
  },
  {
    "title": "Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know",
    "link": "https://finance.yahoo.com/news/pfizer-pfe-stock-sinks-market-214517376.html"
  },
  {
    "title": "Pfizer Declares Second-Quarter 2025 Dividend",
    "link": "https://finance.yahoo.com/news/pfizer-declares-second-quarter-2025-204000919.html"
  },
  {
    "title": "Why Is Summit Therapeutics Stock Soaring On Wednesday?",
    "link": "https://finance.yahoo.com/news/why-summit-therapeutics-stock-soaring-194743694.html"
  },
  {
    "title": "Pfizer Advances Bold Vision for Future of Cancer Care at the ASCO 2025 Annual Meeting",
    "link": "https://finance.yahoo.com/news/pfizer-advances-bold-vision-future-194600237.html"
  },
  {
    "title": "Why vaccine makers aren't worried about Trump administration cuts",
    "link": "https://finance.yahoo.com/news/why-vaccine-makers-arent-worried-about-trump-administration-cuts-185027024.html"
  },
  {
    "title": "3 of Wall Street’s Favorite Stocks Walking a Fine Line",
    "link": "https://finance.yahoo.com/news/3-wall-street-favorite-stocks-130400724.html"
  },
  {
    "title": "2 High-Yield Dividend Stocks to Buy for Passive Income",
    "link": "https://finance.yahoo.com/news/2-high-yield-dividend-stocks-123000741.html"
  },
  {
    "title": "Pfizer Stock Before Q1 Earnings Release: To Buy or Not to Buy?",
    "link": "https://finance.yahoo.com/news/pfizer-stock-q1-earnings-release-105800319.html"
  },
  {
    "title": "What's Next for Pfizer After the Company Pulls Its Weight Loss Drug?",
    "link": "https://finance.yahoo.com/news/whats-next-pfizer-company-pulls-104000218.html"
  },
  {
    "title": "S&P 500 Sell-Off: 2 Ultra-High-Yield Dividend Stocks That Make for No-Brainer Buys",
    "link": "https://finance.yahoo.com/news/p-500-sell-off-2-075100542.html"
  },
  {
    "title": "Novo Nordisk Pops After Leapfrogging Eli Lilly With An Obesity Pill",
    "link": "https://finance.yahoo.com/m/e688a2ac-055a-3925-abe7-cd3cb5566982/novo-nordisk-pops-after.html"
  },
  {
    "title": "Jim Cramer Warns on Pfizer (PFE): “That 7.7% Yield Is Not a Sign of Strength – It’s a Sign of Weakness”",
    "link": "https://finance.yahoo.com/news/jim-cramer-warns-pfizer-pfe-174450309.html"
  },
  {
    "title": "Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for",
    "link": "https://finance.yahoo.com/news/analysts-estimate-pfizer-pfe-report-140058650.html"
  },
  {
    "title": "Pfizer Inc. (PFE): Among Recent Activist Investor Campaigns",
    "link": "https://finance.yahoo.com/news/pfizer-inc-pfe-among-recent-133604076.html"
  },
  {
    "title": "Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know",
    "link": "https://finance.yahoo.com/news/investors-heavily-search-pfizer-inc-130014658.html"
  },
  {
    "title": "Novo shares down on Eli Lilly’s positive obesity pill data",
    "link": "https://finance.yahoo.com/news/novo-shares-down-eli-lilly-083401896.html"
  },
  {
    "title": "Pfizer Inc. (PFE): One of the Safe Dividend Stocks with Yields Above 5%",
    "link": "https://finance.yahoo.com/news/pfizer-inc-pfe-one-safe-141911199.html"
  },
  {
    "title": "How a scrapped Pfizer drug became a winner for SpringWorks",
    "link": "https://finance.yahoo.com/news/scrapped-pfizer-drug-became-winner-080000858.html"
  },
  {
    "title": "How To Put $100 In Your Retirement Fund Each Month With Pfizer Stock",
    "link": "https://finance.yahoo.com/news/put-100-retirement-fund-month-020059807.html"
  },
  {
    "title": "Pfizer Inc. (PFE): Among Jeff Smith’s Top Activist Targets",
    "link": "https://finance.yahoo.com/news/pfizer-inc-pfe-among-jeff-155753664.html"
  },
  {
    "title": "3 Magnificent Stocks to Buy That Are Near 52-Week Lows",
    "link": "https://finance.yahoo.com/news/3-magnificent-stocks-buy-near-123000394.html"
  },
  {
    "title": "Pfizer Abandons Its Leading Weight Loss Candidate. Should You Sell the Stock?",
    "link": "https://finance.yahoo.com/news/pfizer-abandons-leading-weight-loss-121500359.html"
  },
  {
    "title": "3 Magnificent S&P 500 Dividend Stocks Down 11% to 63% to Buy and Hold Forever",
    "link": "https://finance.yahoo.com/news/3-magnificent-p-500-dividend-070500629.html"
  },
  {
    "title": "Why Eli Lilly and Company (LLY) is Skyrocketing?",
    "link": "https://finance.yahoo.com/news/why-eli-lilly-company-lly-063152727.html"
  },
  {
    "title": "Pfizer (PFE) Laps the Stock Market: Here's Why",
    "link": "https://finance.yahoo.com/news/pfizer-pfe-laps-stock-market-214516275.html"
  },
  {
    "title": "US Advisory Panel Votes To Expand Recommendation For Pfizer, GSK's RSV Vaccines For Older Adults Below 60 Years",
    "link": "https://finance.yahoo.com/news/us-advisory-panel-votes-expand-193110268.html"
  },
  {
    "title": "Is Pfizer Inc. (PFE) the Best Large-Cap Value Stock to Buy as the Recession Hits?",
    "link": "https://finance.yahoo.com/news/pfizer-inc-pfe-best-large-185020270.html"
  },
  {
    "title": "Pfizer (NYSE:PFE) Gets CDC Recommendation to Expand ABRYSVO Vaccine Use for RSV Prevention",
    "link": "https://finance.yahoo.com/news/pfizer-nyse-pfe-gets-cdc-172534992.html"
  },
  {
    "title": "Should You Buy, Hold, or Sell BMY Stock Ahead of Q1 Earnings?",
    "link": "https://finance.yahoo.com/news/buy-hold-sell-bmy-stock-170600473.html"
  },
  {
    "title": "Advances in BRAF colorectal cancer treatment further segment the paradigm",
    "link": "https://finance.yahoo.com/news/advances-braf-colorectal-cancer-treatment-160941995.html"
  },
  {
    "title": "Vaccine Stocks Rise on Growing Threat of Bird Flu Infections",
    "link": "https://finance.yahoo.com/news/vaccine-stocks-rise-growing-threat-150800194.html"
  },
  {
    "title": "GSK & PFE's RSV Vaccines Recommended for Use in Adults Aged 50-59",
    "link": "https://finance.yahoo.com/news/gsk-pfes-rsv-vaccines-recommended-132000369.html"
  },
  {
    "title": "Pharma Stock Roundup: J&J's Q1 Results, PFE's Obesity Setback",
    "link": "https://finance.yahoo.com/news/pharma-stock-roundup-j-js-131500764.html"
  },
  {
    "title": "Trump Tariff Plunge: 3 Phenomenal Stocks to Buy at Bargain Prices Right Now",
    "link": "https://finance.yahoo.com/news/trump-tariff-plunge-3-phenomenal-075100309.html"
  },
  {
    "title": "ACIP Votes to Expand Recommendation for Pfizer’s RSV Vaccine ABRYSVO® to Include Adults Aged 50 to 59 at Increased Risk of Disease",
    "link": "https://finance.yahoo.com/news/acip-votes-expand-recommendation-pfizer-201500828.html"
  },
  {
    "title": "Why Pfizer Stock Topped the Market on Tuesday",
    "link": "https://finance.yahoo.com/news/why-pfizer-stock-topped-market-225308409.html"
  },
  {
    "title": "Pfizer Halts Obesity Pill Development Amid Safety Concerns",
    "link": "https://finance.yahoo.com/news/pfizer-halts-obesity-pill-development-165700605.html"
  },
  {
    "title": "BofA keeps Neutral on Pfizer after danuglipron failure as core thesis unchanged",
    "link": "https://finance.yahoo.com/news/bofa-keeps-neutral-pfizer-danuglipron-150532621.html"
  },
  {
    "title": "Smaller obesity drugmakers jump after Pfizer scraps weight-loss pill",
    "link": "https://finance.yahoo.com/news/smaller-obesity-drugmakers-jump-pfizer-143525028.html"
  },
  {
    "title": "NVO, LLY, GPCR & VKTX Stocks Gain Following PFE's Obesity Study Setback",
    "link": "https://finance.yahoo.com/news/nvo-lly-gpcr-vktx-stocks-140000975.html"
  },
  {
    "title": "Is High-Yield Pfizer Stock Still a Buy After Scrapping Its Weight Loss Pill?",
    "link": "https://finance.yahoo.com/news/high-yield-pfizer-stock-still-113900876.html"
  },
  {
    "title": "Why Viking Therapeutics, Inc. (VKTX) Skyrocketed On Monday?",
    "link": "https://finance.yahoo.com/news/why-viking-therapeutics-inc-vktx-044028854.html"
  },
  {
    "title": "Trump Initiates Chips and Drug Probes Ahead of More Tariffs",
    "link": "https://finance.yahoo.com/news/trump-announces-chips-drug-probes-204108780.html"
  },
  {
    "title": "Pfizer hits setback in obesity drug race as GLP-1 trial halts",
    "link": "https://finance.yahoo.com/video/pfizer-hits-setback-obesity-drug-214449466.html"
  },
  {
    "title": "Top Analyst Reports for Bank of America, Chevron & Stryker",
    "link": "https://finance.yahoo.com/news/top-analyst-reports-bank-america-211500618.html"
  },
  {
    "title": "Stocks to Watch Monday: Apple, Palantir, Intel, Pfizer",
    "link": "https://finance.yahoo.com/m/817c5cd5-5458-3016-8ad9-e99851b0f130/stocks-to-watch-monday-.html"
  },
  {
    "title": "Sector Update: Health Care Stocks Rise Monday Afternoon",
    "link": "https://finance.yahoo.com/news/sector-health-care-stocks-rise-180801475.html"
  },
  {
    "title": "Dell stock pops, Pfizer halts GLP-1 pill trial, M&T Bank outlook",
    "link": "https://finance.yahoo.com/video/dell-stock-pops-pfizer-halts-172944323.html"
  },
  {
    "title": "Pfizer (NYSE:PFE) Discontinues Danuglipron Development After Safety Review in Study",
    "link": "https://finance.yahoo.com/news/pfizer-nyse-pfe-discontinues-danuglipron-172306284.html"
  },
  {
    "title": "Pfizer to Discontinue Development of Experimental Weight-Loss Pill Danuglipron",
    "link": "https://finance.yahoo.com/news/pfizer-discontinue-development-experimental-weight-171908293.html"
  },
  {
    "title": "Pfizer Inc. (PFE): “Dead Money… Close the Casket,” Says Jim Cramer",
    "link": "https://finance.yahoo.com/news/pfizer-inc-pfe-dead-money-165323179.html"
  },
  {
    "title": "Pfizer drops obesity pill development after liver injury report",
    "link": "https://finance.yahoo.com/news/pfizer-drops-obesity-pill-development-164502057.html"
  },
  {
    "title": "Top Midday Stories: Stocks Rally on Tariff Exemption News; Pfizer Discontinues Development of Weight-Loss Drug",
    "link": "https://finance.yahoo.com/news/top-midday-stories-stocks-rally-154141521.html"
  },
  {
    "title": "Pfizer's $130B Weight-Loss Dream Just Collapsed",
    "link": "https://finance.yahoo.com/news/pfizers-130b-weight-loss-dream-151831937.html"
  },
  {
    "title": "Pfizer Halts Obesity-Drug Development. What It Means for Eli Lilly, Novo Nordisk.",
    "link": "https://finance.yahoo.com/m/a8dc6bd6-8da6-3a2a-a9bf-f5b52ce3449a/pfizer-halts-obesity-drug.html"
  },
  {
    "title": "Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today",
    "link": "https://finance.yahoo.com/news/why-eli-lilly-novo-nordisk-151230600.html"
  },
  {
    "title": "Pfizer just had a big setback in its race for an Ozempic competitor",
    "link": "https://finance.yahoo.com/news/pfizer-just-had-big-setback-145553640.html"
  },
  {
    "title": "Pfizer, Nvidia, Intel: Stocks in 30",
    "link": "https://finance.yahoo.com/video/pfizer-nvidia-intel-stocks-30-143753704.html"
  },
  {
    "title": "Pfizer Halts Development of Weight-Loss Pill",
    "link": "https://finance.yahoo.com/m/b3673b54-a975-32c1-a871-82025800a9e7/pfizer-halts-development-of.html"
  },
  {
    "title": "Is Pfizer Inc. (PFE) Among the Best Dividend Paying Stocks According to Hedge Funds?",
    "link": "https://finance.yahoo.com/news/pfizer-inc-pfe-among-best-142115898.html"
  },
  {
    "title": "Pfizer Halts Development of Obesity Drug After Patient Sustains 'Liver Injury'",
    "link": "https://finance.yahoo.com/news/pfizer-halts-development-obesity-drug-141357676.html"
  },
  {
    "title": "Pfizer Abandons Obesity Pill After Trial Liver Injury",
    "link": "https://finance.yahoo.com/video/pfizer-abandons-obesity-pill-trial-140656016.html"
  },
  {
    "title": "Pfizer discontinues GLP-1 pill trial, stock trades flat",
    "link": "https://finance.yahoo.com/news/pfizer-discontinues-glp-1-pill-trial-stock-trades-flat-135330797.html"
  },
  {
    "title": "Pfizer ends development of potential pill obesity treatment",
    "link": "https://finance.yahoo.com/news/pfizer-ends-development-potential-pill-124143941.html"
  },
  {
    "title": "Safety worries spur Pfizer to drop another obesity pill",
    "link": "https://finance.yahoo.com/news/safety-worries-spur-pfizer-drop-120500830.html"
  },
  {
    "title": "Pfizer pulls plug on weight-loss pill, citing trial concerns",
    "link": "https://finance.yahoo.com/news/pfizer-pulls-plug-weight-loss-112112412.html"
  },
  {
    "title": "Viking Rallies After Pfizer 'Stumble' Highlights The Takeover Candidate — Again",
    "link": "https://finance.yahoo.com/m/1567ea01-79e9-3d70-a035-a8578b36359c/viking-rallies-after-pfizer.html"
  },
  {
    "title": "Pfizer Provides Update on Oral GLP-1 Receptor Agonist Danuglipron",
    "link": "https://finance.yahoo.com/news/pfizer-provides-oral-glp-1-104500492.html"
  },
  {
    "title": "Stock Market Today: Stocks end higher, tech stalls amid tariff confusion",
    "link": "https://finance.yahoo.com/news/stock-market-today-stocks-higher-100900834.html"
  },
  {
    "title": "Big pharma holds its breath as Trump plots his revenge",
    "link": "https://finance.yahoo.com/news/big-pharma-holds-breath-trump-050000653.html"
  },
  {
    "title": "1 Deeply Undervalued Stock to Buy in the Market Correction",
    "link": "https://finance.yahoo.com/news/1-deeply-undervalued-stock-buy-081800137.html"
  },
  {
    "title": "Pfizer (PFE) Advances But Underperforms Market: Key Facts",
    "link": "https://finance.yahoo.com/news/pfizer-pfe-advances-underperforms-market-214516632.html"
  },
  {
    "title": "Is Pfizer Inc. (PFE) A Cheap NYSE Stock to Invest in According to Hedge Funds?",
    "link": "https://finance.yahoo.com/news/pfizer-inc-pfe-cheap-nyse-203507561.html"
  },
  {
    "title": "Novavax slides after RFK Jr. casts doubts about COVID vaccine",
    "link": "https://finance.yahoo.com/news/novavax-slides-rfk-jr-casts-152014610.html"
  },
  {
    "title": "Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock",
    "link": "https://finance.yahoo.com/news/know-beyond-why-pfizer-inc-130014887.html"
  },
  {
    "title": "6 Stocks With Clear Price Dislocations That I Purchased During Wall Street's Historic Volatility",
    "link": "https://finance.yahoo.com/news/6-stocks-clear-price-dislocations-070600692.html"
  },
  {
    "title": "Select Medical, Phreesia, Eli Lilly, Pfizer, and Brink's Shares Are Falling, What You Need To Know",
    "link": "https://finance.yahoo.com/news/select-medical-phreesia-eli-lilly-171104703.html"
  },
  {
    "title": "Vaxcyte Stock Plummets 56% in a Month: Here's the Reason",
    "link": "https://finance.yahoo.com/news/vaxcyte-stock-plummets-56-month-170700030.html"
  },
  {
    "title": "S&P, Dow Jones Pharma Names Rattled — Again — On Trump's Tariffs Whiplash",
    "link": "https://finance.yahoo.com/m/5788e167-ba2e-3f2d-8e9e-4bfb72e0e2c1/s-p-dow-jones-pharma-names.html"
  },
  {
    "title": "Trump Wants RFK Jr. To 'Go Wild' On Health Care. What This Means For Biotech Stocks.",
    "link": "https://finance.yahoo.com/m/ad410584-ce11-3244-a597-6a1760bc9030/trump-wants-rfk-jr-to-go.html"
  },
  {
    "title": "Pfizer Invites Shareholders to Attend Virtual 2025 Annual Meeting of Shareholders on April 24",
    "link": "https://finance.yahoo.com/news/pfizer-invites-shareholders-attend-virtual-150000793.html"
  },
  {
    "title": "Pfizer Stock Falls to New 52-Week Low: Should You Buy the Dip?",
    "link": "https://finance.yahoo.com/news/pfizer-stock-falls-52-week-134400344.html"
  },
  {
    "title": "Next-generation Covid-19 vaccines currently being tested",
    "link": "https://finance.yahoo.com/news/next-generation-covid-19-vaccines-103050825.html"
  },
  {
    "title": "Zacks.com featured highlights General Motors, JD.com, Pfizer, StoneCo and Enersys",
    "link": "https://finance.yahoo.com/news/zacks-com-featured-highlights-general-090000004.html"
  },
  {
    "title": "Delta, Walmart, pharmaceutical stocks: Market Minute",
    "link": "https://finance.yahoo.com/video/delta-walmart-pharmaceutical-stocks-market-151538726.html"
  },
  {
    "title": "Apple, Alibaba, drugmaker stocks: Trending Tickers",
    "link": "https://finance.yahoo.com/video/apple-alibaba-drugmaker-stocks-trending-144322260.html"
  },
  {
    "title": "Trump says pharmaceutical tariffs may be coming: What to know",
    "link": "https://finance.yahoo.com/video/trump-says-pharmaceutical-tariffs-may-141157823.html"
  },
  {
    "title": "Dow Jones, S&P 500 Pharma Names Recover After Trump Backs Off His Tariffs Plan",
    "link": "https://finance.yahoo.com/m/be7d1b24-7c1e-38ff-91b2-281ea7807568/dow-jones-s-p-500-pharma.html"
  },
  {
    "title": "Trump Tariff News: New Tariffs Begin, China Retaliates; Treasury Yields Spike While Delta, Walmart Pull Guidance",
    "link": "https://finance.yahoo.com/m/a3b4073e-cf6b-3c9f-8915-5acaa3968de0/trump-tariff-news-new.html"
  },
  {
    "title": "Novo Nordisk, AbbVie Stocks Slide After Trump Vows Pharma Tariffs",
    "link": "https://finance.yahoo.com/m/f171bfb7-94e2-3b98-bde2-9d5add357a5c/novo-nordisk-abbvie-stocks.html"
  },
  {
    "title": "Is Pfizer (NYSE:PFE) A Risky Investment?",
    "link": "https://finance.yahoo.com/news/pfizer-nyse-pfe-risky-investment-130015999.html"
  },
  {
    "title": "5 Low Price-to-Book Stocks to Add to Your Portfolio in April",
    "link": "https://finance.yahoo.com/news/5-low-price-book-stocks-125800063.html"
  },
  {
    "title": "Trump Says Pharmaceutical Tariffs Coming ‘Very Shortly’",
    "link": "https://finance.yahoo.com/news/trump-says-pharmaceutical-tariffs-coming-094047688.html"
  },
  {
    "title": "3 High-Yielding Dividend Stocks Near Their 52-Week Lows to Buy Right Now",
    "link": "https://finance.yahoo.com/news/3-high-yielding-dividend-stocks-093200831.html"
  },
  {
    "title": "Pfizer Stock’s Fall to ’97 Level Lifts Yield Near 8%. Dividend Looks Safe.",
    "link": "https://finance.yahoo.com/m/21c833dc-2b10-33f0-afe2-439fc5c81233/pfizer-stock%E2%80%99s-fall-to-%E2%80%9997.html"
  },
  {
    "title": "Biopharma Shakeup: Goldman Boosts J&J, Eli Lilly While Flagging Risks at Pfizer and AbbVie",
    "link": "https://finance.yahoo.com/news/biopharma-shakeup-goldman-boosts-j-175813148.html"
  },
  {
    "title": "Is Pfizer (PFE) Stock Undervalued Right Now?",
    "link": "https://finance.yahoo.com/news/pfizer-pfe-stock-undervalued-now-134010049.html"
  },
  {
    "title": "AbbVie's Rinvoq Gets EU Nod for 8th Indication Giant Cell Arteritis",
    "link": "https://finance.yahoo.com/news/abbvies-rinvoq-gets-eu-nod-131500800.html"
  },
  {
    "title": "Goldman turns cautious on major pharma names, sees select upside at Eli Lilly",
    "link": "https://finance.yahoo.com/news/goldman-turns-cautious-major-pharma-130817424.html"
  },
  {
    "title": "Down 62%, Should You Buy the Dip on Pfizer?",
    "link": "https://finance.yahoo.com/news/down-62-buy-dip-pfizer-084000869.html"
  }
]